SeaStar Medical Holding (ICU) Retained Earnings (2020 - 2026)
SeaStar Medical Holding's (ICU) quarterly Retained Earnings came in at $162.5 million in Q1 2026, up 213.4% YoY from $51.9 million in Q1 2025, and up 207.14% on a QoQ basis from -$151.7 million in Q4 2025.
SeaStar Medical Holding (ICU) Retained Earnings (2020 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 7 years of Retained Earnings data on file, last reported at $162.5 million in Q1 2026.
- Quarterly Retained Earnings rose 213.4% year-over-year to $162.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $162.5 million (up 213.4% YoY) and the FY2025 annual result came in at -$151.7 million, down 210.43% from the prior year.
- Retained Earnings improved to $162.5 million in Q1 2026, from -$151.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $162.5 million in Q1 2026 to a low of -$151.7 million in Q4 2025.
- A 5-year average of $21.1 million and a median of $67.7 million in 2022 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 1105.92% in 2023, down 1301.22% in 2023.
- Tracing ICU's Retained Earnings over 5 years: stood at $67.7 million in 2022, then jumped by 48.9% to $100.9 million in 2023, then soared by 36.2% to $137.4 million in 2024, then plunged by 210.43% to -$151.7 million in 2025, then soared by 207.14% to $162.5 million in 2026.
- The last three Retained Earnings figures came in at $162.5 million (Q1 2026), -$151.7 million (Q4 2025), and $160.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 4.38 Bn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 163.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 163.26 Mn |
| Mar 31, 2026 | 162.55 Mn |
| Dec 31, 2025 | -151.71 Mn |
| Sep 30, 2025 | 160.27 Mn |
| Jun 30, 2025 | -145.34 Mn |
| Mar 31, 2025 | -143.34 Mn |
| Dec 31, 2024 | 137.38 Mn |
| Sep 30, 2024 | 133.09 Mn |
| Jun 30, 2024 | 123.77 Mn |
| Mar 31, 2024 | -127.43 Mn |
| Dec 31, 2023 | 100.86 Mn |
| Sep 30, 2023 | 89.26 Mn |
| Jun 30, 2023 | -98.05 Mn |
| Mar 31, 2023 | 72.22 Mn |
| Dec 31, 2022 | 67.74 Mn |
| Sep 30, 2022 | -8.90 Mn |
| Jun 30, 2022 | -7.00 Mn |
| Mar 31, 2022 | -7.18 Mn |
| Dec 31, 2021 | -76.31 Mn |
| Sep 30, 2021 | -10.68 Mn |